NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Dec 18, 2014
Insider Transaction Report
Form 4
Regan William J.
SVP of lobal Regulatory Strate
Transactions
- Award
Stock Option (Right to Buy)
2014-12-17+25,000→ 25,000 totalExercise: $1.50Exp: 2024-12-17→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Option vests as to 6,250 shares upon grant, with balance vesting at the rate of 6,250 shares on January 28 in each of 2016, 2017 and 2018.